Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain metastases: epidemiology and pathophysiology.

Igor T Gavrilovic1, Jerome B Posner

  • 1Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Journal of Neuro-Oncology
|October 11, 2005
PubMed
Summary

Brain metastases are common CNS tumors, but their incidence is underestimated due to incomplete data. Understanding the complex pathophysiology of brain metastases is crucial for developing targeted therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment.

Neuro-oncology practice·2026
Same author

Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem Gliomas.

JCO precision oncology·2026
Same author

Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine for newly diagnosed primary CNS lymphoma.

Neuro-oncology·2026
Same author

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.

Acta neuropathologica·2025
Same author

Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma.

Neuro-oncology·2025
Same author

Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series.

Neurology·2022

Area of Science:

  • Neuro-oncology
  • Cancer Metastasis Research
  • Central Nervous System (CNS) Tumors

Background:

  • Metastases are the most frequent central nervous system (CNS) tumors.
  • Cancer databases often underestimate the incidence of brain metastases.
  • Brain imaging is not standard for asymptomatic patients, and autopsy data is outdated.

Purpose of the Study:

  • To highlight the increasing incidence of brain metastases.
  • To emphasize the importance of understanding brain metastases pathophysiology.
  • To explore potential therapeutic targets for brain tumor growth.

Main Methods:

  • Review of existing literature on brain metastases incidence and pathophysiology.
  • Analysis of factors contributing to the underestimation of brain metastases.

Related Experiment Videos

  • Discussion of the multistage process of brain metastases formation.

    • Main Results:

    • The incidence of brain metastases appears to be increasing, contrasting with stable cancer rates and decreasing mortality.
    • Current data collection methods likely underestimate the true incidence.
    • Brain metastases involve a complex multistage process with molecular underpinnings.

    Conclusions:

    • Further research into the pathophysiology of brain metastases is essential.
    • Understanding molecular mechanisms can lead to novel therapeutic strategies.
    • Targeting the CNS environment may inhibit tumor progression.